William E. Falk

1.2k total citations
31 papers, 940 citations indexed

About

William E. Falk is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, William E. Falk has authored 31 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in William E. Falk's work include Treatment of Major Depression (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Tryptophan and brain disorders (4 papers). William E. Falk is often cited by papers focused on Treatment of Major Depression (9 papers), Neuroscience and Neuropharmacology Research (6 papers) and Tryptophan and brain disorders (4 papers). William E. Falk collaborates with scholars based in United States and Vietnam. William E. Falk's co-authors include Joanne Wojcik, Andrew W. Brotman, Alan J. Gelenberg, Mark H. Pollack, Jeanette Günther, Guochuan Tsai, Joseph B. Biederman, J F Rosenbaum, John B. Herman and Joseph T. Coyle and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

William E. Falk

31 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Falk United States 15 473 243 132 120 114 31 940
Saulo C. M. Ribeiro United States 10 298 0.6× 238 1.0× 154 1.2× 85 0.7× 137 1.2× 11 790
Cecilia A. Peabody United States 18 313 0.7× 133 0.5× 212 1.6× 119 1.0× 53 0.5× 38 955
J.-P. Olié France 16 423 0.9× 218 0.9× 214 1.6× 151 1.3× 134 1.2× 37 1.1k
David M. Marks United States 15 345 0.7× 220 0.9× 110 0.8× 84 0.7× 126 1.1× 29 953
Charles S. Wilcox United States 16 275 0.6× 320 1.3× 135 1.0× 127 1.1× 73 0.6× 27 806
James F. Pradko United States 6 540 1.1× 389 1.6× 72 0.5× 157 1.3× 116 1.0× 6 1.2k
P. J. Perry United States 12 526 1.1× 216 0.9× 52 0.4× 138 1.1× 89 0.8× 20 872
Conrad M. Swartz United States 21 903 1.9× 554 2.3× 77 0.6× 104 0.9× 104 0.9× 115 1.4k
L. Pepplinkhuizen Netherlands 22 309 0.7× 149 0.6× 130 1.0× 141 1.2× 164 1.4× 65 1.3k
Jack Hirschowitz United States 22 812 1.7× 164 0.7× 209 1.6× 272 2.3× 125 1.1× 63 1.4k

Countries citing papers authored by William E. Falk

Since Specialization
Citations

This map shows the geographic impact of William E. Falk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Falk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Falk more than expected).

Fields of papers citing papers by William E. Falk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Falk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Falk. The network helps show where William E. Falk may publish in the future.

Co-authorship network of co-authors of William E. Falk

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Falk. A scholar is included among the top collaborators of William E. Falk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Falk. William E. Falk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daly, Ella, William E. Falk, & Patrick R. Brown. (2001). Cholinesterase inhibitors for behavioral disturbance in dementia. Current Psychiatry Reports. 3(3). 251–258. 3 indexed citations
2.
Tsai, Guochuan, William E. Falk, Jeanette Günther, & Joseph T. Coyle. (1999). Improved Cognition in Alzheimer’s Disease With Short-Term D-Cycloserine Treatment. American Journal of Psychiatry. 156(3). 467–469. 98 indexed citations
3.
Falk, William E.. (1999). Neurobiology of Primary Dementia. Psychosomatics. 40(3). 265–266. 8 indexed citations
4.
Tsai, Guochuan, William E. Falk, & Jeanette Günther. (1998). A Preliminary Study of d-Cycloserine Treatment in Alzheimer's Disease. Journal of Neuropsychiatry. 10(2). 224–226. 29 indexed citations
5.
Falk, William E.. (1995). Dementia and Normal Aging. Psychosomatics. 36(6). 581–583. 51 indexed citations
6.
Falk, William E., et al.. (1992). The Dementias: Diagnosis and Management. Psychosomatics. 33(4). 466–467. 4 indexed citations
7.
Fava, Maurizio, Jerrold F. Rosenbaum, Robert A. MacLaughlin, et al.. (1990). Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. Journal of Psychiatric Research. 24(2). 177–184. 17 indexed citations
8.
Gelenberg, Alan J., Joanne Wojcik, William E. Falk, et al.. (1990). Tyrosine for depression: a double-blind trial. Journal of Affective Disorders. 19(2). 125–132. 55 indexed citations
9.
Rosenbaum, Jerrold F., Maurizio Fava, William E. Falk, et al.. (1990). The antidepressant potential of oral S‐adenosyl‐l‐methionine*. Acta Psychiatrica Scandinavica. 81(5). 432–436. 57 indexed citations
10.
Herman, John B., Andrew W. Brotman, Mark H. Pollack, et al.. (1990). Fluoxetine-induced sexual dysfunction.. PubMed. 51(1). 25–7. 150 indexed citations
11.
Gelenberg, Alan J., et al.. (1990). Clovoxamine in the treatment of depressed outpatients: A double-blind, parallel-group comparison against amitriptyline and placebo. Comprehensive Psychiatry. 31(4). 307–314. 9 indexed citations
12.
Gelenberg, Alan J., et al.. (1989). CDP-Choline for the treatment of tardive dyskinesia: A small negative series. Comprehensive Psychiatry. 30(1). 1–4. 14 indexed citations
13.
Sachs, G S, et al.. (1989). Ergoloid mesylates and ECT.. PubMed. 50(3). 87–90. 10 indexed citations
14.
Gelenberg, Alan J., Theodore Van Putten, Philip W. Lavori, et al.. (1989). Anticholinergic effects on memory: benztropine versus amantadine.. PubMed. 9(3). 180–5. 35 indexed citations
15.
Falk, William E., et al.. (1989). Fluoxetine Versus Trazodone in Depressed Geriatric Patients. Journal of Geriatric Psychiatry and Neurology. 2(4). 208–214. 57 indexed citations
16.
Eisenthal, Sherman & William E. Falk. (1988). Medication Decisions and the Risk of Tardive Dyskinesia. Psychological Reports. 62(2). 467–472. 1 indexed citations
17.
Putten, Theodore Van, Alan J. Gelenberg, William E. Falk, et al.. (1987). Anticholinergic effects on memory: benztropine vs. amantadine.. PubMed. 23(1). 26–9. 11 indexed citations
18.
Falk, William E., Alan J. Gelenberg, & Joanne Wojcik. (1985). Amoxapine for the Treatment of Psychotically Depressed Subjects. The Journal of Nervous and Mental Disease. 173(2). 90–93. 6 indexed citations
19.
Falk, William E.. (1979). Lithium Prophylaxis of Corticotropin-lnduced Psychosis. JAMA. 241(10). 1011–1011. 106 indexed citations
20.
Falk, William E., et al.. (1977). [Autonomous thyroid adenoma in an 11 years old girl with childhood hyperthyroidism (author's transl)].. PubMed. 125(4). 207–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026